Details
Stereochemistry | ACHIRAL |
Molecular Formula | 3C6H4NO2.Cr.H2O |
Molecular Weight | 436.3158 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.[Cr+3].[O-]C(=O)C1=NC=CC=C1.[O-]C(=O)C2=NC=CC=C2.[O-]C(=O)C3=NC=CC=C3
InChI
InChIKey=XIGVJNARZKLHPA-UHFFFAOYSA-K
InChI=1S/3C6H5NO2.Cr.H2O/c3*8-6(9)5-3-1-2-4-7-5;;/h3*1-4H,(H,8,9);;1H2/q;;;+3;/p-3
Molecular Formula | HO |
Molecular Weight | 17.0073 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Cr |
Molecular Weight | 51.9961 |
Charge | 3 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C6H5NO2 |
Molecular Weight | 123.1094 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Chromium sulfate(III) hexahydrate or chromium sulphate, a trivalent compound of chromium that was investigated as a toxic compound. Experiments on rodent have shown chromium sulfate produced severe and widespread effects in the nasal cavity, larynx, lungs, and mediastinal lymph node. Effects were characterized by the accumulation of foreign material, infiltration of alveolar macrophages, septal cell hyperplasia, and granulomatous and chronic inflammation. Besides, chromium sulphate exerted a disadvantageous effect on the skeleton, as it decreases bone density and resistance.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0004714 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15924436 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | CHROMIUM Approved UseChromium 4 mcg/mL (Chromic Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. Administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. Launch Date1.12000316E12 |
PubMed
Title | Date | PubMed |
---|---|---|
Thirteen-week subchronic rat inhalation toxicity study with a recovery phase of trivalent chromium compounds, chromic oxide, and basic chromium sulfate. | 1999 Dec |
|
Status of antioxidant defense system in chromium-induced Swiss mice tissues. | 2004 Jul |
|
The role of oxidative stress in the modulation of aryl hydrocarbon receptor-regulated genes by As3+, Cd2+, and Cr6+. | 2005 Dec 1 |
|
Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium. | 2007 Aug |
|
Effects of subchronic exposure via drinking water to a mixture of eight water-contaminating metals: a biochemical and histopathological study in male rats. | 2007 Nov |
|
Immunosuppressive effect of subchronic exposure to a mixture of eight heavy metals, found as groundwater contaminants in different areas of India, through drinking water in male rats. | 2007 Oct |
|
The peripheral quantitative computed tomographic and densitometric analysis of skeletal tissue in male Wistar rats after chromium sulfate treatment. | 2017 Sep 21 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:14:55 UTC 2023
by
admin
on
Sat Dec 16 08:14:55 UTC 2023
|
Record UNII |
M6EBS2L3CB
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID8031025
Created by
admin on Sat Dec 16 08:14:55 UTC 2023 , Edited by admin on Sat Dec 16 08:14:55 UTC 2023
|
PRIMARY | |||
|
22833491
Created by
admin on Sat Dec 16 08:14:55 UTC 2023 , Edited by admin on Sat Dec 16 08:14:55 UTC 2023
|
PRIMARY | |||
|
M6EBS2L3CB
Created by
admin on Sat Dec 16 08:14:55 UTC 2023 , Edited by admin on Sat Dec 16 08:14:55 UTC 2023
|
PRIMARY | |||
|
144710-94-1
Created by
admin on Sat Dec 16 08:14:55 UTC 2023 , Edited by admin on Sat Dec 16 08:14:55 UTC 2023
|
ALTERNATIVE | |||
|
27882-76-4
Created by
admin on Sat Dec 16 08:14:55 UTC 2023 , Edited by admin on Sat Dec 16 08:14:55 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ANHYDROUS->SOLVATE |